These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37086890)

  • 1. Epidemiology and risk factors for carbapenemase-producing Enterobacteriaceae carriage in the hospital: A population-based nested case-control study.
    Fan M; Wong SC; Yu Q; Li PH; Wu P; Chan EWY; Wong ICK; Tun HM; Cowling BJ; Cheng VC; Chui CSL
    J Glob Antimicrob Resist; 2023 Jun; 33():242-248. PubMed ID: 37086890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.
    Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M
    Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Genomic Characterization of Carbapenemase-producing Enterobacteriaceae (CPE) Reveals Changing Pattern of CPE Isolated in Hong Kong Hospitals.
    Zhu C; Li C; Lai CKC; Ng R; Chau KY; Wong KT; Lo NWS; Barua N; Yang Y; Liyanapathirana V; Hui M; Lai RW; Fung KSC; Tsang DN; Ip M
    Int J Antimicrob Agents; 2021 Nov; 58(5):106430. PubMed ID: 34525401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016.
    van den Bunt G; van Pelt W; Hidalgo L; Scharringa J; de Greeff SC; Schürch AC; Mughini-Gras L; Bonten MJM; Fluit AC
    Euro Surveill; 2019 Oct; 24(41):. PubMed ID: 31615600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and Transmission of Carbapenemase-Producing
    Aung AH; Kanagasabai K; Koh J; Hon PY; Ang B; Lye D; Chen SL; Chow A
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0258420. PubMed ID: 34001509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae.
    Hayakawa K; Nakano R; Hase R; Shimatani M; Kato H; Hasumi J; Doi A; Sekiya N; Nei T; Okinaka K; Kasahara K; Kurai H; Nagashima M; Miyoshi-Akiyama T; Kakuta R; Yano H; Ohmagari N
    J Antimicrob Chemother; 2020 Mar; 75(3):697-708. PubMed ID: 31789374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
    Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
    Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
    Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Intra-Abdominal Infections Caused by Carbapenemase-Producing
    Mora-Guzmán I; Rubio-Perez I; Domingo-Garcia D; Martin-Perez E
    Surg Infect (Larchmt); 2021 Oct; 22(8):864-870. PubMed ID: 33857380
    [No Abstract]   [Full Text] [Related]  

  • 12. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.
    Marimuthu K; Ng OT; Cherng BPZ; Fong RKC; Pada SK; De PP; Ooi ST; Smitasin N; Thoon KC; Krishnan PU; Ang MLT; Chan DSG; Kwa ALH; Deepak RN; Chan YK; Chan YFZ; Huan X; Zaw Linn K; Tee NWS; Tan TY; Koh TH; Lin RTP; Hsu LY; Sengupta S; Paterson DL; Perencevich E; Harbarth S; Teo J; Venkatachalam I;
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015.
    Eda R; Nakamura M; Takayama Y; Maehana S; Nakano R; Yano H; Kitasato H
    J Infect Chemother; 2020 Jul; 26(7):667-671. PubMed ID: 32222331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017.
    Iacchini S; Sabbatucci M; Gagliotti C; Rossolini GM; Moro ML; Iannazzo S; D'Ancona F; Pezzotti P; Pantosti A
    Euro Surveill; 2019 Jan; 24(5):. PubMed ID: 30722813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carbapenemase producing Enterobacteriaceae in the Netherlands: unnoticed spread to several regions].
    Leenstra T; Bosch T; Vlek AL; Bonten MJM; van der Lubben IM; de Greeff SC
    Ned Tijdschr Geneeskd; 2017; 161():D1585. PubMed ID: 29076442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Characteristics of Extended-Spectrum-β-Lactamase-Producing and Carbapenemase-Producing
    Sapugahawatte DN; Li C; Zhu C; Dharmaratne P; Wong KT; Lo N; Ip M
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32295872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating serial screening cultures to detect carbapenemase-producing Enterobacteriaceae following hospital admission.
    Mookerjee S; Dyakova E; Davies F; Bamford K; Brannigan ET; Holmes A; Otter JA
    J Hosp Infect; 2018 Sep; 100(1):15-20. PubMed ID: 29883616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active case finding for carbapenemase-producing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization.
    Poole K; George R; Decraene V; Shankar K; Cawthorne J; Savage N; Welfare W; Dodgson A
    J Hosp Infect; 2016 Oct; 94(2):125-9. PubMed ID: 27542962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
    Marimuthu K; Venkatachalam I; Khong WX; Koh TH; Cherng BPZ; Van La M; De PP; Krishnan PU; Tan TY; Choon RFK; Pada SK; Lam CW; Ooi ST; Deepak RN; Smitasin N; Tan EL; Lee JJ; Kurup A; Young B; Sim NTW; Thoon KC; Fisher D; Ling ML; Peng BAS; Teo YY; Hsu LY; Lin RTP; Ong RT; Teo J; Ng OT;
    Clin Infect Dis; 2017 May; 64(suppl_2):S68-S75. PubMed ID: 28475792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.